AMIE HART: Open Payments
NPI 1902234297 · COLORADO SPRINGS, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$216 in 10 payments from 6 companies in 2025. Trend: 2023 $64 · 2024 $246 · 2025 $216
Food & beverage: $216
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 3 | $72 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $62 |
| Neurocrine BioSciences, Inc. | 1 | $21 |
| Alkermes, Inc. | 1 | $21 |
| Lundbeck LLC | 1 | $21 |
| Axsome Therapeutics, Inc. | 1 | $20 |
Products named: REXULTI, CAPLYTA, INGREZZA, ARISTADA, Auvelity.
Industry payments across CO — which companies pay providers there.
